Clinical Trials Browser

Phase 2 × Neoplasm Metastasis × Azacitidine × Clear all

NCT00384956 2016-12-12

A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes

Phase 2 Completed

25 enrolled 13 charts

Myelodysplastic Syndromes, Neoplasm Metastasis